A Senate plan to tackle patient cost-sharing for insulin is estimated to increase the federal deficit by $23.3 bn over a decade, about double the impact of the insulin-provisions in a similar House bill.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?